The Pediatric Dermatologist's View of Pediatric Vitiligo.
J Drugs Dermatol
; 23(2): e77-e78, 2024 Feb 01.
Article
en En
| MEDLINE
| ID: mdl-38306136
ABSTRACT
BACKGROUND:
No guidelines exist for pediatric vitiligo.OBJECTIVE:
To identify practice patterns of pediatric dermatologists treating vitiligo.METHODS:
A PeDRA survey was completed online by 56 pediatric dermatologists.RESULTS:
Practitioners reported feeling most comfortable treating 13- to 17-year-olds and least comfortable treating infants. Quality of life was assessed by interview in 89.3%. Topical calcineurin inhibitors (TCIs), topical corticosteroids (TCSs), narrowband UVB, coverup makeup, topical JAK inhibitors (tJAKis), and 308-nm laser were the leading vitiligo therapeutics chosen. 94.5% of practitioners reported experiencing frustration due to difficulties procuring therapies.CONCLUSION:
Pediatric vitiligo has notable effects on quality of life. Some therapeutic options exist which are preferred by pediatric dermatologists. There is a need for more data on therapeutics in infants and young children, J Drugs Dermatol. 2024;23(2) doi10.36849/JDD.7572e.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Terapia Ultravioleta
/
Vitíligo
/
Fármacos Dermatológicos
Tipo de estudio:
Guideline
/
Qualitative_research
Idioma:
En
Revista:
J Drugs Dermatol
Asunto de la revista:
DERMATOLOGIA
Año:
2024
Tipo del documento:
Article